Revelation Biosciences- Warrants(10/01/2027) Current Cash

The latest current cash for REVBW is $14M as of March 2026. That compares with $3.7M in the prior-year period — up 281.0% year over year. Investors often review this figure alongside Revelation Biosciences- Warrants(10/01/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, REVBW's current cash moved from $3.7M to $14M — a 281.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Revelation Biosciences- Warrants(10/01/2027)'s operating scale or balance-sheet position.

A current cash figure of $14M for REVBW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting REVBW's current cash ($14M), review year-over-year change from $3.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.